Cardiac and vascular effects of long-term losartan treatment in stroke- prone spontaneously hypertensive rats

Hypertension

Volumn 28, Issue 3, 1996, Pages 397-402

  Gohlke, Peter ^a   Linz, Wolfgang ^b   Schölkens, Bernward A ^b   Wiemer, Gabriele ^b   Unger, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b SANOFI   (France)

Author keywords

angiotensin converting enzyme inhibitors; cyclic GMP; heart; losartan; rat, stroke prone SHR; receptors, angiotensin

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRADYKININ B2 RECEPTOR; CREATINE KINASE; CREATINE PHOSPHATE; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOGEN; ICATIBANT; LACTATE DEHYDROGENASE; LACTIC ACID; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HYPERTENSION; LONG TERM EXPOSURE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE;

EID: 0029834299     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.397     Document Type: Article

References (39)

1. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995;47:25-49.
2. Liu Y-H, Yang X-P, Sharov VG, Sigmon DH, Sabbah HN, Carretero OA. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension. 1996;27:7-13.
3. Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Frew M, Goodfriend T, Harding JW, Inagami T, Timmermans PBMWM. Proposed update of angiotensin receptor nomenclature. Hypertension. 1995;25:924-927.
4. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-251.
5. Camargo MJF, Von Lutterotti N, Campbell WG Jr, Pecker MS, James GD, Timmermans PBMWM, Laragh JH. Control of blood pressure and end-organ damage in maturing salt-loaded stroke prone spontaneously hypertensive rats by oral angiotensin II receptor blockade. J Hypertens. 1993;11:31-40.
6. Fornes P, Richer C, Vacher E, Bruneval P, Giudicelli JF. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal. J Cardiovasc Pharmacol. 1993;22:305-313.
7. Stier CT Jr, Adler LA, Levine S, Chander PN. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens. 1993;11(suppl 3):S37-S42.
8. Stier CTJ, Benter IF, Ahmad S, Zuo H, Selig N, Roethel S, Levine S, Itskovitz HD. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension. 1989;13:115-121.
9. Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin converting enzyme inhibition improves cardiac function; role of bradykinin. Hypertension. 1994;23;411-418.
10. Gohlke P, Kuwer I, Bartenbach S, Schnell A, Unger T. Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin. J Cardiovasc Pharmacol. 1994;24:462-469.
11. Gohlke P, Lamberty V, Kuwer I, Bartenbach S, Schnell A, Linz W, Schölkens BA, Wiemer G, Unger T. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3′,5′-monophosphate. Hypertension. 1993;22:682-687.
12. Linz W, Schölkens BA, Han YF. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. J Cardiovasc Pharmacol. 1986;8(suppl 10):S91-S99.
13. Noll F. L-(+)-Lactate. In: Bergemeyer HU, Bergemeyer J, Grassl M, eds. Methods of Enzymatic Analysis. Metabolites I: Carbohydrates. Deerfield Beach, Fla: Weinheim/Basel, Switzerland: Verlag Chemie; 1984;6:582-588.
14. Vassault A. Lactate dehydrogenase. UV-method with pyruvate and NADH. In: Bergemeyer HU, Bergemeyer J, Grassl M, eds. Methods of Enzymatic Analysis. Enzymes 1: Oxidoreductases, Transferases. Deerfield Beach, Fla: Weinheim/Basel, Switzerland: Verlag Chemie; 1983;13:118-126.
15. Gerhardt W. Creatine kinase. Routine UV-method. In: Bergemeyer HU, Bergemeyer J, Grassl M, eds. Methods of Enzymatic Analysis. Enzymes 1: Oxidoreductases, Transferases. Deerfield Beach, Fla: Weinheim/Basel, Switzerland: Verlag Chemie; 1983;3:510-518.
16. Keppler D, Decker K. Glycogen. In: Bergemeyer HU, Bergemeyer J, Grassl M, eds. Methods of Enzymatic Analysis. Metabolites 1: Carbohydrates. Deerfield Beach, Fla: Weinheim/Basel, Switzerland: Verlag Chemie; 1984;6:11-18.
17. Trautschold I, Lamprecht W, Schweitzer G. Adenosine-5-triphosphate. UV-method with hexokinase and glycose-6-phosphate dehydrogenase. In: Bergemeyer HU, Bergemeyer J, Grassl M, eds. Methods of Enzymatic Analysis. Metabolites 2: Tri- and Dicarboxylic Acids, Purines, Pyrimidines and Derivates, Coenzymes, Inorganic Compounds. Deerfield Beach, Fla: Weinheim/Basel, Switzerland: Verlag Chemie; 1985;7:346-357.
18. Heinz F, Weisser H. Creatine phosphate. In: Bergemeyer HU, Bergemeyer J, Grassl M, eds. Methods of Enzymatic Analysis. Metabolites 3: Lipids, Amino Acids and Related Compounds. Deerfield Beach, Fla: Weinheim/Basel, Switzerland: Verlag Chemie; 1985;8: 507-514.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
20. Campbell DJ, Kladis A, Valentijn AJ. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. J Cardiovasc Pharmacol. 1995;26:233-240.
21. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993;268:24543-24546.
22. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of type 2 angiotensin H receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 1993;268:24539-24542.
23. 2 receptor subtype. In: Saavedra JM, Timmermans PB, eds. Angiotensin Receptors. New York, NY: Plenum Press: 1994:95-117.
24. 2 receptor: searching for signal-transduction pathways and physiological function. Trends Pharmacol Sci. 1995;16:223-225.
25. Smith RD, Timmermans PB. Human angiotensin receptor subtypes. Curr Opin Nephrol Hypertens. 1994;3:112-122.
26. Metsärinne KP, Stoll M, Gohlke P, Paul M, Unger T. Angiotensin II is antiproliferative for coronary endothelial cells in vitro. Pharm Pharmacol Lett. 1992;2:150-152.
27. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
28. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res. 1992;71:1482-1489.
29. Suzuki J, Matsubara H, Urakami M, Inada M. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res. 1993;73:439-447.
30. 2 receptor subtypes in hypertrophied rat hearts. Am J Physiol. 1994;267:H844-H852.
31. Timmermans PB, Smith RD. Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur Heart J. 1994; 15:79-87.
32. Wiemer G, Schölkens BA, Busse R, Wagner A, Heitsch H, Linz W. The functional role of angiotensin II, subtype AT2, receptors in endothelial cells and isolated ischemic rat hearts. Pharm Pharmacol Lett. 1993;3:24-27.
33. SeyediN, Xu XB, Nasjiletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
34. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
35. Sim MK, Singh M. Decreased responsiveness of the aortae of hypertensive rats to acetylcholine, histamine and noradrenaline. Br J Pharmacol 1987;90:147-150.
36. Shimamura K, Osugi S, Moiyama K, Sunano S. Impairment and protection of endothelium-dependent relaxation in aortae of various strains of spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1991;17(suppl 3):S133-S136.
37. Shirasaki Y, Kolm P, Nickols GA, Lee TJ-F. Endothelial regulation of cyclic GMP and vascular responses in hypertension. J Pharmacol Exp Ther. 1988;245:53-58.
38. Munzenmaier DH, Greene AS. Stimulation of soluble guanylate cyclase activity by angiotensin II is mediated by a non-AT1 receptor mechanism in rat aorta. FASEB J. 1994;8:A367. Abstract.
39. Holtz J, Munzel T, Sommer O, Bassenge E. Converting enzyme inhibition by enalapril in experimental heart failure. Nephron. 1990;55(suppl 1):73-76.